Case Summary:

North America Immigration Law Group has recently secured approval for an I-140 EB1A (Alien of Extraordinary Ability) petition from the USCIS for a Postdoctoral Fellow in the field of neuroscience. His work had a significant influence on the entire field, and his achievements are of the utmost importance due to their direct applicability in global efforts to address the need to protect those on insulin therapies against the risk of hypoglycemia.

In order to qualify for an EB1A visa, the applicant must have accomplished the pinnacle of their field, according to USCIS’s regulatory requirements. This case demonstrates the additional challenges the client had since USCIS adjudicators occasionally create novel and nearly insurmountable provisions that surpass the strict requirements that apply to this category.

Therefore, we vigilantly reviewed our client’s research background and planned a petition package that was most suited for him. We convincingly stated that he had dedicated his extraordinary research efforts to the field of neuroscience, focusing on advancing our understanding of how the brain integrates and responds to endocrine signals in the context of metabolic homeostasis.

Due to the rising prevalence of diabetes and obesity in the United States, research on the deterministic mechanisms of such diseases requires attention and investment. Accordingly, our client’s work on energy expenditure regulation from the brain has proven results in progressing the development of therapeutics to target glucose dysregulation, with significant applications in treating diabetes and obesity. Thus, it is obvious that he plays an instrumental role in advancing this research in the United States.

Moreover, his extraordinary influence in the field is discussed more specifically below.

• We found that he has authored and co-authored 22 peer-reviewed journal articles (8 first-authored and 1 co-first-authored) published in international journals and conference proceedings.
• In total, his publications have gathered 252 citations from at least 30 countries, showing that indeed his contributions to the field have been invaluable.
• Besides, we affirmed that our client has conducted 28 reviews for highly acclaimed journals to date.
• Also, his extraordinary ability in the field is additionally reflected by his research funded by the NIH and the AHA, both of which are highly prestigious organizations funding world-class health-related research.

Furthermore, we added four recommendation letters to his petition packet, corroborating his impressive history of publication, track record in academia, and skills in animal model research. One of them stated the following:

“Overall, [client] has discovered key molecular components that play critical roles in brain-body homeostasis. It is clear that his contributions thus far have expanded neuroscience research in the United States, with applications in drug development and improving effective treatments. His unique skills in mouse and shrew modeling are required to pioneer this research area. Based on this, I recommend that he remain in the United States to continue his research.”

Upon reviewing our client’s research background, it is unmistakable that he is a major figure in advancing the study of neuroscience in the United States, as substantiated by his internationally acclaimed publications. Therefore, he is an irreplaceable asset and must continue his research to the benefit of the United States. In just 6 days, our client successfully secured the EB1A approval, thanks to a premium processing service upgrade. We sincerely thank him for working with us over the entire process and for putting his trust in our law firm. We wish him well in all of his future undertakings.